Literature DB >> 7703253

Molecular basis for prokaryotic specificity of magainin-induced lysis.

E M Tytler1, G M Anantharamaiah, D E Walker, V K Mishra, M N Palgunachari, J P Segrest.   

Abstract

Magainins and mastoparans are examples of peptide antibiotics and peptide venoms, respectively. They have been grouped together as class L amphipathic helixes [Segrest, J.P., et al. (1990) Proteins 8, 103-117] because of similarities in the distribution of Lys residues along the polar face of the helix. Class L venoms lyse both eukaryotic and prokaryotic cells whereas class L antibiotics specifically lyse bacteria. The structural basis for the specificity of class L antibiotics is not well understood. Sequence analysis showed that class L antibiotics have a Glu residue on the nonpolar face of the amphipathic helix; this is absent from class L venoms. We synthesized three model class L peptides with or without Glu on the nonpolar face: 18LMG (LGSIWKFIKAFVGGIKKF), [E14]18LMG and [G5,E14]18LMG. Hemolysis, bacteriolysis, and bacteriostasis studies using these peptides showed that the specificity of lysis is due to both the presence of a Glu residue on the nonpolar face of the helix and the bulk of the nonpolar face. Studies using large unilamellar phospholipid vesicles showed that the inclusion of cholesterol greatly inhibited leakage by the two Glu-containing peptides. These results cannot be attributed to changes in the phase behavior of the lipids caused by the inclusion of cholesterol or to differences in the secondary structure of the peptides. These results suggest that eukaryotic cells are resistant to lysis by magainins because of peptide-cholesterol interactions in their membranes that inhibit the formation of peptide structures capable of lysis, perhaps by hydrogen bonding between Glu and cholesterol. Bacterial membranes, lacking cholesterol, are susceptible to lysis by magainins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7703253     DOI: 10.1021/bi00013a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens.

Authors:  M Mota-Meira; G LaPointe; C Lacroix; M C Lavoie
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Hydrophobic hydration of amphipathic peptides.

Authors:  Y K Cheng; W S Sheu; P J Rossky
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

3.  Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles.

Authors:  F Nicol; S Nir; F C Szoka
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

Review 4.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 5.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

6.  A novel, multilayer structure of a helical peptide.

Authors:  K S Taylor; M Z Lou; T M Chin; N C Yang; R M Garavito
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

Review 7.  Alpha-helical cationic antimicrobial peptides: relationships of structure and function.

Authors:  Yibing Huang; Jinfeng Huang; Yuxin Chen
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

Review 8.  Sequential and Structural Aspects of Antifungal Peptides from Animals, Bacteria and Fungi Based on Bioinformatics Tools.

Authors:  Karuna Singh; Jyoti Rani
Journal:  Probiotics Antimicrob Proteins       Date:  2016-06       Impact factor: 4.609

9.  Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin.

Authors:  H Zhao; J P Mattila; J M Holopainen; P K Kinnunen
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

10.  Membrane composition determines pardaxin's mechanism of lipid bilayer disruption.

Authors:  Kevin J Hallock; Dong-Kuk Lee; John Omnaas; Henry I Mosberg; A Ramamoorthy
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.